AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 SEP 5 - (NewsRx.com & NewsRx.net) --
by N.R. Saltmarsh, staff medical writer - Chimpanzees vaccinated with virus-like particles (VLPs) of human papillomavirus (HPV) are able to mount antibody and cytokine responses to various HPV types, a finding that holds promise for human vaccine development.
"We evaluated antibody, cytokine (interferon-gamma, interleukin-5, tumor necrosis factor-alpha), and cytotoxic T lymphocyte (CTL) responses in chimpanzees immunized with monovalent or quadrivalent (HPV-6, -11, -16, -18) L1 VLP vaccines administered intramuscularly on aluminum hydroxyphosphate (alum) at weeks 0, 8 and 24," reported T.J. Palker and colleagues working in the United States.
The researchers employed radioimmunoassay (RIA) four weeks after the second and third immunizations to measure maximum serum antibody titers to type-specific, neutralizing epitopes on HPV-11 or -16 L1 VLPs. They found that, depending on the VLP type used for immunization, HPV type-specific cytokine responses were most frequently seen four weeks after the second or third immunizations and between weeks 44-52.
HPV-16 L1-specific CTL activity was observed only from weeks 16-24 in 3 of 22 (13.6%) chimpanzees immunized with HPV-16 L1 VLPs, they noted ("Antibody, ...